![](/img/cover-not-exists.png)
The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Kenneth Sall, the Brinzolamide Primary Therapy Study GroupVolume:
44
Year:
2000
Language:
english
DOI:
10.1016/s0039-6257(99)00107-1
File:
PDF, 120 KB
english, 2000